BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24507104)

  • 21. Intravascular Large B-Cell Lymphoma of the Gallbladder.
    Çetin B; Akyürek N; Metin Y; Karaca F; Bilgetekin İ; Özet A
    Turk J Haematol; 2018 May; 35(2):145-146. PubMed ID: 29391332
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical characterization of 61 cases of diffuse large B-cell lymphoma with different prognosis].
    Wang Q; Wei XD; Yin QS
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):136-7. PubMed ID: 22780933
    [No Abstract]   [Full Text] [Related]  

  • 23. The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma.
    Kim HK; Park CJ; Jang S; Cho YU; Park SH; Choi J; Park CS; Huh J; Chung YH; Lee JH
    Ann Lab Med; 2015 Jan; 35(1):152-4. PubMed ID: 25553299
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinicopathological and molecular genetic characteristics of childhood diffuse large B cell lymphoma].
    Huang H; Yang WP; Xu HY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):209-11. PubMed ID: 22780976
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolated central nervous system relapse in a patient with systemic diffuse large B-cell lymphoma: Diagnostic and treatment challenges.
    Das P; Dubashi B; Joseph D; Jain A
    Indian J Cancer; 2014; 51(4):468-9. PubMed ID: 26842164
    [No Abstract]   [Full Text] [Related]  

  • 26. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
    George A; Tam CS; Seymour JF
    Leuk Lymphoma; 2013 Dec; 54(12):2575-6. PubMed ID: 23597141
    [No Abstract]   [Full Text] [Related]  

  • 27. [Primary cutaneous follicle centre lymphoma: report of a case].
    Rong YF; He LM; Zhang YS; Feng YZ
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):769-70. PubMed ID: 24447559
    [No Abstract]   [Full Text] [Related]  

  • 28. Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trial.
    Mounier N; Heutte N; Thieblemont C; Briere J; Gaulard P; Feugier P; Ghesquieres H; Van Den Neste E; Robu D; Tilly H; Bouabdallah R; Safar V; Coiffier B;
    Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):151-4. PubMed ID: 22301063
    [No Abstract]   [Full Text] [Related]  

  • 29. Asymptomatic gastrosplenic fistula in a patient with marginal zonal lymphoma transformed to diffuse large B cell lymphoma--a case report and review of literature.
    Senapati J; Devasia AJ; Sudhakar S; Viswabandya A
    Ann Hematol; 2014 Sep; 93(9):1599-602. PubMed ID: 24362455
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis of a primary cardiac B-cell lymphoma.
    Menke J; Unterberg-Buchwald C; Schaefer IM; Kertesz A
    Am J Hematol; 2012 Apr; 87(4):426-7. PubMed ID: 21953722
    [No Abstract]   [Full Text] [Related]  

  • 31. A treatment for activated B-cell-like DLBCL?
    Zinzani PL
    Lancet Oncol; 2014 Aug; 15(9):916-7. PubMed ID: 25042201
    [No Abstract]   [Full Text] [Related]  

  • 32. R2-CHOP vs R-CHOP for diffuse large B-cell lymphoma.
    Fowler NH
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):608-10. PubMed ID: 25654483
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased rituximab (R) doses eliminate increased risk and improve outcome of elderly male patients with aggressive CD20+ B-cell lymphomas: the SEXIE-R-CHOP-14 trial of the DSHNHL.
    Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):8-9. PubMed ID: 25768993
    [No Abstract]   [Full Text] [Related]  

  • 34. Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?
    Mondello P; Cuzzocrea S; Pitini V; Aloisi C; Mian M
    Acta Oncol; 2015 Jun; 54(6):953-5. PubMed ID: 25831143
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphoma with massive cardiac involvement.
    Flores Umanzor EJ; Caldentey Adrover G; Rodriguez Londres J; San Antonio R; Diaz Mejía NM
    Acta Cardiol; 2016; 71(5):621-622. PubMed ID: 27695024
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
    Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
    Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary diffuse large B-Cell lymphoma of the prostate presenting with urinary retention and dyschezia for which rituximab-combined CHOP therapy was effective-a case presentation.
    Manabe M; Hayashi Y; Yoshii Y; Mukai S; Sakamoto E; Kanashima H; Nakao T; Hayama T; Fukushima H; Inoue T; Yamane T; Teshima H
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1733-5. PubMed ID: 23152030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Mediastinal Large B-Cell Lymphoma As an Incidental Finding: Report of a Case.
    Yönal-Hindilerden İ; Hindilerden F; Arslan S; Doğan İÖ; Nalçacı M
    Turk J Haematol; 2018 May; 35(2):141-142. PubMed ID: 27094863
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neoplastic counterpart of interfollicular dendritic large B cells: report of a case].
    Liu YH; Li M; Zhang F; Zhuang HG; Luo XL
    Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):276-7. PubMed ID: 22800529
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP.
    Ribera JM; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M; Navarro JT; Feliu E
    Br J Haematol; 2012 Jun; 157(5):637-9. PubMed ID: 22313456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.